The initial phases of biomarker identification heavily rely on untargeted discovery proteomics, utilizing data-dependent acquisition (DDA) or data-independent acquisition (DIA) mass spectrometry.
Phase I study of everolimus (RAD001) and AMG 479 in patients (pts) with advanced solid tumors and colorectal cancer (CRC). This is an ASCO Meeting Abstract from the 2011 ASCO Annual Meeting I. This ...
A next-generation multitarget stool DNA test, including assessments of DNA molecular markers and hemoglobin level, was developed to improve the performance of colorectal cancer screening, primarily ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results